{
    "organizations": [],
    "uuid": "6dce5d705b5b8fcee11b79ee5bd772e13adc1b04",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-theravance-biopharma-reports-qtrly/brief-theravance-biopharma-reports-qtrly-loss-per-share-1-22-idUSASC0A0MT",
    "ord_in_thread": 0,
    "title": "BRIEF-Theravance Biopharma Reports Qtrly Loss Per Share $1.22",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Theravance Biopharma Inc:\n* THERAVANCE BIOPHARMA, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* QTRLY LOSS PER SHARE $1.22 * Q1 EARNINGS PER SHARE VIEW $-1.26 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T05:00:00.000+03:00",
    "crawled": "2018-05-09T12:35:49.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "theravance",
        "biopharma",
        "inc",
        "theravance",
        "biopharma",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "qtrly",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}